EPHX2 and metabolic disease: Although the mechanism by which these EETs prevent metabolic diseases is not completely understood, inflammation and chronic diseases, such as cardiovascular diseases, have been associated with increased sEH expression and accelerated conversion of omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) [14].